Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-13-051678
Filing Date
2013-09-20
Accepted
2013-09-20 10:02:11
Documents
4
Period of Report
2013-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v355518_6k.htm 6-K 16445
2 EXHIBIT 10.1 v355518_ex10-1.htm EX-10.1 261849
3 EXHIBIT 10.2 v355518_ex10-2.htm EX-10.2 159205
4 EXHIBIT 99.1 v355518_ex99-1.htm EX-99.1 10785
  Complete submission text file 0001144204-13-051678.txt   449390
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 000-54749 | Film No.: 131106879
SIC: 2834 Pharmaceutical Preparations